These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8793231

  • 1. Skeletal muscle metabolism before and after gemfibrozil treatment in dialysed patients with chronic renal failure.
    Thompson CH, Irish A, Kemp GJ, Taylor DJ, Radda GK.
    Clin Nephrol; 1996 Jun; 45(6):386-9. PubMed ID: 8793231
    [Abstract] [Full Text] [Related]

  • 2. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Jun; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 3. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
    Thompson CH, Irish AB, Kemp GJ, Taylor DJ, Radda GK.
    Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867
    [Abstract] [Full Text] [Related]

  • 4. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
    Vaux EC, Taylor DJ, Altmann P, Rajagopalan B, Graham K, Cooper R, Bonomo Y, Styles P.
    Nephron Clin Pract; 2004 Jun; 97(2):c41-8. PubMed ID: 15218329
    [Abstract] [Full Text] [Related]

  • 5. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M, Collins D, Robins S, Bloomfield H, Curhan GC.
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [Abstract] [Full Text] [Related]

  • 6. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M, Anarat A, Bayazit AK, Noyan A, Ozel A, Anarat R, Aydingülü H, Dikmen N.
    Turk J Pediatr; 2002 Nov; 44(1):40-4. PubMed ID: 11858378
    [Abstract] [Full Text] [Related]

  • 7. Impaired muscle oxygen metabolism in uremic children: improved after renal transplantation.
    Matsumoto N, Ichimura S, Hamaoka T, Osada T, Hattori M, Miyakawa S.
    Am J Kidney Dis; 2006 Sep; 48(3):473-80. PubMed ID: 16931221
    [Abstract] [Full Text] [Related]

  • 8. The time course of haemodynamic, autonomic and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in man.
    Adamopoulos S, Kemp GJ, Thompson CH, Arnolda L, Brunotte F, Stratton JR, Radda GK, Rajagopalan B, Kremastinos DT, Coats AJ.
    J Mol Cell Cardiol; 1999 Oct; 31(10):1913-26. PubMed ID: 10525428
    [Abstract] [Full Text] [Related]

  • 9. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
    Balogh Z, Seres I, Harangi M, Kovács P, Kakuk G, Paragh G.
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
    [Abstract] [Full Text] [Related]

  • 10. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T.
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [Abstract] [Full Text] [Related]

  • 11. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
    Kamaliah MD, Sanjay LD.
    Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054
    [Abstract] [Full Text] [Related]

  • 12. Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil.
    Elisaf MS, Dardamanis MA, Papagalanis ND, Siamopoulos KC.
    Scand J Urol Nephrol; 1993 Aug; 27(1):101-8. PubMed ID: 8493456
    [Abstract] [Full Text] [Related]

  • 13. Hyperlipidemia in continuous ambulatory peritoneal dialysis patients.
    Lal SM.
    ASAIO J; 1993 Aug; 39(2):87-8. PubMed ID: 8324266
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G, Irish A, Chan D, Watts G.
    Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
    [Abstract] [Full Text] [Related]

  • 15. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Jun; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 16. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW.
    Curr Med Res Opin; 2001 Jun; 17(1):60-73. PubMed ID: 11464448
    [Abstract] [Full Text] [Related]

  • 17. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
    Ozdemir O, Boran M, Gökçe V, Uzun Y, Koçak B, Korkmaz S.
    Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
    [Abstract] [Full Text] [Related]

  • 18. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A, Hamsten A, Silveira A, Fatah K, Goodall AH, Eriksson M, Angelin B, Hjemdahl P.
    Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.